Clinical Trials
6
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)Serranator POINT FORCE Registry
Recruiting
- Conditions
- Peripheral Artery Disease (PAD)Dysfunctional AV FistulaDysfunctional AV Graft
- First Posted Date
- 2024-11-13
- Last Posted Date
- 2025-02-13
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 500
- Registration Number
- NCT06687590
- Locations
- 🇺🇸
UT Southwestern, Dallas, Texas, United States
Serrantor OCT Study
Not Applicable
Recruiting
- Conditions
- Critical Limb Ischemia
- Interventions
- Device: Serranator PTA Serration CatheterDrug: PTA (Standard of Care)
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 60
- Registration Number
- NCT06434194
- Locations
- 🇺🇸
Columbia University, New York, New York, United States
🇺🇸Weill Cornell Medical, New York, New York, United States
Serranator Recoil Study
Not Applicable
- Conditions
- Critical Limb IschemiaPeripheral Arterial Disease
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 20
- Registration Number
- NCT05161039
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
🇩🇪Klinik für Angiologie, Klinikum Hochsauerland GmbH, Arnsberg, Germany
The PRELUDE BTK Study
Not Applicable
Completed
- Conditions
- Critical Limb IschemiaPeripheral Arterial Disease
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- Cagent Vascular LLC
- Target Recruit Count
- 49
- Registration Number
- NCT03693963
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
🇩🇪Klinikum Hochsauerland GmbH, Arnsberg, Germany
🇩🇪Krankenhaus Buchholz, Buchholz, Germany
Serranator® Alto Post Market Clinical Follow Up (PMCF) Study
Withdrawn
- Conditions
- Arterio-venous FistulaPeripheral Arterial DiseaseArteriovenous Graft
- First Posted Date
- 2018-05-29
- Last Posted Date
- 2020-04-10
- Lead Sponsor
- Cagent Vascular LLC
- Registration Number
- NCT03538392
- Prev
- 1
- 2
- Next
News
No news found